Moleculin Reports Positive Phase 2/3 MIRACLE Interim Results, With Annamycin Complete Remission Rates 3-fold Greater than Control

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/24/2026

1. INTC
2. DECK
3. META
4. AMD
5. INFY
6. SPY
7. UNP
8. GOOGL
9. RNG
10. DGX

Go back to Moleculin Reports Positive Phase 2/3 MIRACLE Interim Results, With Annamycin Complete Remission Rates 3-fold Greater than Control
METABASIS THERAPEUT (NASDAQ: MBRX) Delayed: 2.12 +0.04 (1.92%)
Previous Close $2.08    52 Week High $9.58 
Open $2.12    52 Week Low $2.34 
Day High $2.13    P/E N/A 
Day Low $2.07    EPS $-0.34 
Volume 44,369